I was born extremely prematurely, at 23 weeks, back in 1990. I was fortunate enough to be enrolled on a research study which tested artificial surfactant, a detergent-like substance which helps the lungs inflate fully when breathing and stops them from collapsing – a major problem in very premature babies with underdeveloped lungs. All these years on, not only am I fit and healthy but surfactant replacement therapy has proven to be incredibly successful and a major factor in the increased survival rates of very premature babies.
My experience made me want to get involved with Bliss’ new Research Grant Fund as a public panel member. I wanted to ensure that the researchers of today get the chance to make a similar difference for the babies of the future.